Jacqueline Zummo

Sr. Vice President, Research, Proteon Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Apr 8, 2026Sold 1,134 shares at $5.40 of Proteon Therapeutics²
Apr 1, 2026Sold 22,598 shares at $5.26 of Proteon Therapeutics³
Jan 26, 2026Shares withheld for tax 3,724 shares at $6.67 of Proteon Therapeutics⁴
Jan 20, 2026Shares withheld for tax 6,578 shares at $5.60 of Proteon Therapeutics⁵
Jan 16, 2026Granted 30,000 shares of Proteon Therapeutics⁶
Mar 26, 2025Sold 21,224 shares at $4.53 of Proteon Therapeutics⁷
Jan 24, 2025Granted 24,500 shares of Proteon Therapeutics⁸
Jan 21, 2025Shares withheld for tax 6,554 shares at $4.76 of Proteon Therapeutics⁹
Jan 3, 2025Shares withheld for tax 2,157 shares at $6.14 of Proteon Therapeutics¹⁰
Jan 19, 2024Shares withheld for tax 3,049 shares at $1.91 of Proteon Therapeutics¹¹
Jan 19, 2024Granted 23,000 shares of Proteon Therapeutics¹¹
Jan 10, 2024Shares withheld for tax 5,229 shares at $2.39 of Proteon Therapeutics¹²
Jan 3, 2024Shares withheld for tax 1,899 shares at $2.17 of Proteon Therapeutics¹³
Jan 19, 2023Granted 19,900 shares of Proteon Therapeutics¹⁴
Jan 10, 2023Shares withheld for tax 5,225 shares at $3.00 of Proteon Therapeutics¹⁵
Jan 3, 2023Shares withheld for tax 2,159 shares at $2.80 of Proteon Therapeutics¹⁶
Jan 10, 2022Shares withheld for tax 4,603 shares at $6.27 of Proteon Therapeutics¹⁷
Jan 3, 2022Granted 14,100 shares of Proteon Therapeutics¹⁸

The numbers on this page point here. Each one links to the record it came from.